Clinical proteomics reveals vulnerabilities in non-invasive breast ductal carcinoma and drives personalized treatment strategies. https://www.biorxiv.org/content/10.1101/2023.07.11.548580v1?med=mas
Clinical proteomics reveals vulnerabilities in non-invasive breast ductal carcinoma and drives personalized treatment strategies. https://www.biorxiv.org/content/10.1101/2023.07.11.548580v1?med=mas